Anti‐N‐homocysteine‐protein autoantibodies are associated with impaired cognition
Abstract Introduction Elevated homocysteine (Hcy) and related metabolites accelerate Alzheimer's disease. Hcy‐lowering B vitamins slow brain atrophy/cognitive decline in mild cognitive impairment (MCI). Modification with Hcy‐thiolactone generates auto‐immunogenic N‐Hcy‐protein. We tested a hypo...
Main Authors: | Olga Włoczkowska, Joanna Perła‐Kaján, A. David Smith, Celeste deJager, Helga Refsum, Hieronim Jakubowski |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
Subjects: | |
Online Access: | https://doi.org/10.1002/trc2.12159 |
Similar Items
-
Cerebrospinal Fluid Homer-3 Autoantibodies in a Patient with Amnestic Mild Cognitive Impairment
by: Niels Hansen, et al.
Published: (2023-01-01) -
Case report: Amnestic mild cognitive impairment in multiple domains associated with neurofascin 186 autoantibodies: Case series with follow-up and review
by: Niels Hansen, et al.
Published: (2023-01-01) -
Homocysteine – A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia
by: Ines Elisabeth Futschek, et al.
Published: (2023-02-01) -
Immunotherapy with corticosteroids in anti-neural autoantibody-associated cognitive impairment: Retrospective case series
by: Niels Hansen, et al.
Published: (2022-09-01) -
Application of Periventricular White Matter Hyperintensities Combined with Homocysteine into Predicting Mild Cognitive Impairment in Parkinson’s Disease
by: Zhang Z, et al.
Published: (2023-02-01)